Was the Cosmos Health (COSM) CEO’s share acquisition under a Rule 10b5-1 trading plan?

The transaction is reported as a Debt Exchange Agreement , and the Form 4’s Rule 10b5-1 checkbox is not marked. This indicates the 766,284-share acquisition was not reported as being executed under a pre-arranged Rule 10b5-1 trading plan.

Cosmos Health (NASDAQ: COSM) CEO swaps $140,000 debt for 766,284 new shares

Q: What insider transaction did Cosmos Health (COSM) report for CEO Grigorios Siokas?

CEO Grigorios Siokas acquired 766,284 shares of Cosmos Health common stock at $0.1827 per share under a Debt Exchange Agreement, canceling $140,000 of company debt owed to him and raising his direct ownership to 14,248,092 shares .

Q: How many Cosmos Health (COSM) shares did the CEO obtain and at what price?

Grigorios Siokas obtained 766,284 common shares of Cosmos Health at an Exchange Rate of $0.1827 per share , which the company describes as the fair market value of the common stock on July 29, 2026 under the Debt Exchange Agreement.

Q: What is the value of debt exchanged in the Cosmos Health (COSM) CEO’s Form 4 transaction?

The CEO exchanged $140,000 in debt that Cosmos Health owed to him for 766,284 Exchange Shares . This debt-for-equity swap used an Exchange Rate of $0.1827 per share , corresponding to the stated fair market value on July 29, 2026.

Filing Impact

(High)

Filing Sentiment

(Positive)

Form Type

Rhea-AI Filing Summary

Siokas Grigorios reported reported purchase transactions in this Form 4 filing.

Cosmos Health Inc. Chief Executive Officer and 10% owner Grigorios Siokas acquired 766,284 shares of common stock at $0.1827 per share on July 29, 2026 under a Debt Exchange Agreement. He received these Exchange Shares in return for $140,000 of company debt owed to him, increasing his direct holdings to 14,248,092 shares.

Insights

Analyzing...

Insider Trade Summary

Net Buyer: 766,284 shares

Net Buy 1 txn

Insider Siokas Grigorios

Role Chief Executive Officer

Bought 766,284 shs ($140K)

Type	Security	Shares	Price	Value
Purchase	Common Stock, par value $.001 ^F1	766,284	$0.1827	$140K

Holdings After Transaction: Common Stock, par value $.001 — 14,248,092 shares (Direct)

Footnotes (1)

F1. Pursuant to a debt exchange agreement by and between Grigorios Siokas, the Company's CEO and the Company (the "Debt Exchange Agreement"), dated as of July 29, 2026, these shares are Exchange Shares (as defined in the Debt Exchange Agreement) being acquired by Mr. Siokas at the Exchange Rate (as defined in the Debt Exchange Agreement) of $0.1827 per share, the fair market value of the Common Stock on July 29, 2026, in exchange for a total amount of $140,000 in debt the Company owed to Mr. Siokas.

Key Figures

Shares acquired: 766,284 shares Exchange Rate: $0.1827 per share Debt exchanged: $140,000 +2 more

5 metrics

Shares acquired 766,284 shares Exchange Shares received by CEO Grigorios Siokas under the Debt Exchange Agreement

Exchange Rate $0.1827 per share Fair market value of common stock on July 29, 2026 used in the debt exchange

Debt exchanged $140,000 Total amount of company debt owed to Mr. Siokas converted into Exchange Shares

Shares owned after transaction 14,248,092 shares Direct common stock holdings of Grigorios Siokas following the exchange

Agreement date July 29, 2026 Date of the Debt Exchange Agreement setting the fair market value and Exchange Rate

Key Terms

Debt Exchange Agreement, Exchange Shares, Exchange Rate, fair market value

4 terms

Debt Exchange Agreement financial

"Pursuant to a debt exchange agreement by and between Grigorios Siokas..."

Exchange Shares financial

"these shares are Exchange Shares (as defined in the Debt Exchange Agreement)"

Exchange Rate financial

"being acquired by Mr. Siokas at the Exchange Rate of $0.1827 per share"

Exchange rate is the price of one currency expressed in another—for example, how many euros you receive for one US dollar. It matters to investors because changes in that price alter the reported profits, costs and value of assets for companies and portfolios that operate or hold money across borders; think of it like switching measurement units, where the same item can look bigger or smaller depending on the unit used.

fair market value financial

"the Exchange Rate of $0.1827 per share, the fair market value of the Common Stock"

The price a willing buyer and a willing seller would agree on for an asset or security when neither is under pressure and both have access to the same information. Think of it as the market’s neutral estimate of what something is worth, like the price two neighbors would settle on for a car after comparing similar listings. Investors care because fair market value guides buying and selling decisions, tax reporting, portfolio valuation, and how accurately company assets are reflected in financial statements.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 07/30/2026 - 11:09 AM Accepted by SEC EDGAR 07/30/2026 - 11:09 AM

FAQ

What insider transaction did Cosmos Health (COSM) report for CEO Grigorios Siokas?

CEO Grigorios Siokas acquired 766,284 shares of Cosmos Health common stock at $0.1827 per share under a Debt Exchange Agreement, canceling $140,000 of company debt owed to him and raising his direct ownership to 14,248,092 shares.

How many Cosmos Health (COSM) shares did the CEO obtain and at what price?

Grigorios Siokas obtained 766,284 common shares of Cosmos Health at an Exchange Rate of $0.1827 per share, which the company describes as the fair market value of the common stock on July 29, 2026 under the Debt Exchange Agreement.

What is the value of debt exchanged in the Cosmos Health (COSM) CEO’s Form 4 transaction?

The CEO exchanged $140,000 in debt that Cosmos Health owed to him for 766,284 Exchange Shares. This debt-for-equity swap used an Exchange Rate of $0.1827 per share, corresponding to the stated fair market value on July 29, 2026.

What is Grigorios Siokas’s Cosmos Health (COSM) shareholding after this transaction?

Following the debt-for-equity exchange, Grigorios Siokas directly holds 14,248,092 shares of Cosmos Health common stock. This total reflects his previous holdings plus the 766,284 Exchange Shares received for canceling $140,000 of company debt under the Debt Exchange Agreement.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Siokas Grigorios

(Last)

(First)

(Middle)

5 AG. GEORGIOU STR.

(Street)

PILEA

THESSALONIKI

TK57001

(City)

(State)

(Zip)

GREECE

(Country)

2. Issuer Name and Ticker or Trading Symbol
Cosmos Health Inc. [ COSM ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	X	10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Executive Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
07/29/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock, par value $.001	07/29/2026	07/29/2026	P⁽¹⁾		766,284	A	$0.1827	14,248,092	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. Pursuant to a debt exchange agreement by and between Grigorios Siokas, the Company's CEO and the Company (the "Debt Exchange Agreement"), dated as of July 29, 2026, these shares are Exchange Shares (as defined in the Debt Exchange Agreement) being acquired by Mr. Siokas at the Exchange Rate (as defined in the Debt Exchange Agreement) of $0.1827 per share, the fair market value of the Common Stock on July 29, 2026, in exchange for a total amount of $140,000 in debt the Company owed to Mr. Siokas.

	/s/ Grigorios Siokas	07/30/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR